Ticker SPGRListed on Nasdaq Stockholm
Abera Bioscience AB
At a glance
Most recent filing on July 22, 2026 — an open-market purchase by Mats Lundgren on Jul 20, 2026.
Over the past 12 months: 13 open-market purchases and 0 open-market sales.
We hold 46 visible filings, going back to November 12, 2020.
Filings we could not classify with confidence are set aside for review, so they are in none of these counts.
Insider trades
What is a MAR filing?5 of 46 shown
- Mats Lundgren Other senior executive328,000 SEKOpen-market buy
- Linus Norén Board member67,628 SEKOpen-market buy
- MiRé Holding AB Closely associated: Chief financial officer41,885 SEKOpen-market buy
- MiRé Holding AB Closely associated: Chief financial officer59,401 SEKOpen-market buy
- Peter Gönczi Chief executive officer129,935 SEKOpen-market buy